3-BETA-ACETOXY-16-BETA-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YLMETHYL)-ANDROST-5-EN-17-BETA-OL
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 4AeTMs6K2rv |
|---|---|
| InChI | InChI=1S/C27H39N3O3/c1-16(31)33-20-8-10-26(2)19(13-20)6-7-21-22(26)9-11-27(3)23(21)12-18(25(27)32)14-30-15-24(28-29-30)17-4-5-17/h6,15,17-18,20-23,25,32H,4-5,7-14H2,1-3H3/t18-,20+,21-,22+,23+,25+,26+,27+/m1/s1 |
| InChIKey | CUVMCOZZGGXBDV-GUIMVGJQSA-N |
| Mol Weight | 453.6 g/mol |
| Molecular Formula | C27H39N3O3 |
| Exact Mass | 453.299142 g/mol |
| Enantiomer InChIKey | CUVMCOZZGGXBDV-VXFNSOGUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
3-BETA-ACETOXY-16-BETA-[4-(4-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-[4-(3-TOLYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
16-BETA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-ALPHA-DIOL-DIACETATE
16-ALPHA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-BETA-DIOLACETATE
16-ALPHA-ACETYLOXYMETHYL-ANDROST-5-EN-3-BETA-17-ALPHA-DIOLACETATE
3,17a-Diacetoxy-16a-methyleneacetoxy.delta. 5(6)-androsten
16-BETA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-BETA-DIOLACETATE
(16R) Ethyl 3,16-diacetoxy-20-methyl-24-nor-chol-5-en-23-oate
acetic acid [(3S,8S,9S,10R,13S,14S,16S,17S)-17-acetyl-16-glyceryl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] ester
Pregn-5-en-20-one, 3-(acetyloxy)-16-methoxy-, (3.beta.,16.alpha.)-
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and In Vitro Antiproliferative Activity of Novel Androst-5-ene Triazolyl and Tetrazolyl Derivatives | Molecules | 2011 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.